J. David Enloe, Jr
2020
In 2020, J. David Enloe, Jr earned a total compensation of $1.1M as President and Chief Executive Officer at Recro Pharma.
Compensation breakdown
| Option Awards | $400,544 |
|---|---|
| Salary | $10,577 |
| Stock Awards | $660,001 |
| Other | $1,678 |
| Total | $1,072,800 |
Enloe received $660K in stock awards, accounting for 62% of the total pay in 2020.
Enloe also received $400.5K in option awards, $10.6K in salary and $1.7K in other compensation.
Rankings
In 2020, J. David Enloe, Jr's compensation ranked 8,338th out of 13,090 executives tracked by ExecPay. In other words, Enloe earned more than 36.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,338 out of 13,090 | 36th |
Division Manufacturing | 3,541 out of 5,624 | 37th |
Major group Chemicals And Allied Products | 1,433 out of 2,257 | 37th |
Industry group Drugs | 1,246 out of 1,957 | 36th |
Industry Pharmaceutical Preparations | 922 out of 1,462 | 37th |
Source: SEC filing on March 25, 2021.
Enloe's colleagues
We found two more compensation records of executives who worked with J. David Enloe, Jr at Recro Pharma in 2020.